• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.69% Nasdaq Up 0.44%

    Arrowhead Research Corp. (ARWR)

    -NasdaqGS
    6.19 Down 0.10(1.51%) Jul 29, 4:00PM EDT
    Add to Portfolio
    Prev Close:6.28
    Open:6.23
    Bid:6.00 x 100
    Ask:6.89 x 1000
    1y Target Est:9.50
    Beta:2.4
    Next Earnings Date: 4-Aug-15ARWR Earnings announcement
    Day's Range:6.01 - 6.30
    52wk Range:4.95 - 17.42
    Volume:994,126
    Avg Vol (3m):1,020,890
    Market Cap:368.00M
    P/E (ttm):N/A
    EPS (ttm):-1.58
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARWR

    Comparison

    Symbol% ChgMkt Cap
    ARWRDown 1.51%368.00M
    PENCUp 8.00%17.41M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,237.25
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-15) :-1.71
    Quarterly EPS Est (Jun-15) :-0.38
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.53

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arrowhead Research Corporation develops novel drugs to treat intractable diseases in the United States. The company’s principal product candidates comprise ARC-520, an RNAi-based therapeutic that is in Phase IIa clinical trial to treat chroni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback